The healthcare nanotechnology market is projected to grow from $308.03 billion in 2023 to $351.82 billion in 2024, with a CAGR of 14.2%, driven by rising cancer cases and advancements in nanomedicine. By 2028, the market is expected to reach $613.9 billion, fueled by innovations in theranostics and personalized medicine. North America led the market in 2023, highlighting the region's significant role in this expanding field.
The North America oncology drugs market, valued at USD 10.13 billion in 2023, is projected to grow at a CAGR of 10.38%, reaching USD 27.20 billion by 2033. Key drivers include advances in cancer research, rising cancer prevalence, and increasing demand for personalized medicine, while challenges include high drug costs and stringent regulations. The market is segmented into cytotoxic, targeted, and hormonal drugs, with targeted therapies expected to dominate due to their effectiveness and reduced toxicity.
Sana Biotechnology is laying off staff and shifting its focus to B-cell associated autoimmune diseases and Type 2 diabetes, discontinuing its cancer and neurological programs. The company, which has seen its share value plummet over 80% since its IPO, aims to partner on its remaining therapies while prioritizing research that could enhance its value by 2026.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.